Synapse - Nursing

Search Within

Nursing

Results (3756)

A "no-wash" albumin-dextran dilution strategy for cord blood (CB) thaw is associated with a high rate of engraftment and a low incidence of serious infusion reactions

Meeting Abstract

Rice, R. D.; Abboud, M.; Hawke, R. M.; Schaible, A. M.; Heller, G.; Scaradavou, A.; Barker, J. N.
Biology of Blood and Marrow Transplantation (2009)

Fulltext@MSK | Save

Cardiac complications of cancer

Book Section

Bartels, M. N.; Leight, M.
In Stubblefield, M. D.; O'Dell, M. W. (Eds.) Cancer Rehabilitation: Principles and Practice. 1st ed (2009)

Fulltext@MSK | Save

A phase I study of XL281, a selective oral RAF kinase inhibitor, in patients (Pts) with advanced solid tumors

Meeting Abstract

Schwartz, G. K.; Robertson, S.; Shen, A.; Wang, E.; Pace, L.; Dials, H.; Mendelson, D.; Shannon, P.; Gordon, M.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase II study of bevacizumab in combination with cetuximab plus irinotecan in irinotecan-refractory colorectal cancer (CRC) patients who have progressed on a bevacizumab-containing regimen (The BOND 2.5 Study)

Meeting Abstract

Segal, N. H.; Reidy-Lagunes, D.; Capanu, M.; Kemeny, N.; Chung, K.; Kelsen, D.; Hollywood, E.; Goodman-Davis, N.; Saltz, L. B.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Hereditary diffuse gastric cancer (HDGC): Clinical characteristics of a prospective cohort of HDGC patients with and without CDH1 mutation and patients with sporadic GC

Meeting Abstract

Shah, M. A.; Pristyazhnyuk, Y.; Jhawer, M.; Coombes, S.; Harlan, M.; Randazzo, J.; Perera, R. J.; Pascarelli, K. M.; Coit, D.; Kelsen, D. P.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

The influence of margin width and volume of disease near margin on benefit of radiation therapy after breast-conserving surgery for DCIS: Results of long-term follow-up

Meeting Abstract

Rudloff, U.; Brogi, E.; McCormick, B.; Brockway, J. P.; Goldberg, J. I.; Wynveen, C. A.; Reiner, A. S.; Patil, S.; Van Zee, K. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II study of intravenous (IV) and intraperitoneal (IP) paclitaxel, IP cisplatin, and IV bevacizumab as first-line chemotherapy for optimal stage II or III ovarian, primary peritoneal, and fallopian tube cancer

Meeting Abstract

Konner, J. A.; Grabon, D.; Pezzulli, S.; Iasonos, A.; Sabbatini, P.; Hensley, M.; Bell-McGuinn, K.; Tew, W.; Spriggs, D.; Aghajanian, C.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Phase I trial of RAD001 (everolimus) plus sunitinib in patients with metastatic renal cell carcinoma

Meeting Abstract

Kroog, G. S.; Feldman, D. R.; Kondagunta, G. V.; Ginsberg, M. S.; Fischer, P. M.; Trinos, M. J.; Patil, S.; Ishill, N. M.; Motzer, R. J.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

Analysis of survival with modified docetaxel, cisplatin, fluorouracil (mDCF), and bevacizumab (BEV) in patients with metastatic gastroesophageal (GE) adenocarcinoma: Results of a phase II clinical trial

Meeting Abstract

Kelsen, D.; Jhawer, M.; Ilson, D.; Tse, A.; Randazzo, J.; Robinson, E.; Capanu, M.; Shah, M. A.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save

A phase II study of sunitinib on a continuous dosing schedule in patients (pts) with relapsed or refractory urothelial carcinoma (UC)

Meeting Abstract

Gallagher, D. J.; Milowsky, M. I.; Gerst, S. R.; Tickoo, S.; Ishill, N.; Regazzi, A.; Trout, A.; Bajorin, D. F.
Journal of Clinical Oncology (2009)

Fulltext@MSK | Save